CTRI/2011/07/001904
Completed
未知
A Non-Interventional, Multi-centric Study to Compare Hepatic fat and Relevant Metabolic Parameters in Overweight/Obese Prediabetic/Diabetic Subjects, with Healthy Subjects in different geographical regions in India
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Diabetic patients
- Sponsor
- Torrent Pharmaceuticals Limited
- Enrollment
- 150
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •For Patients:
- •1\.Ethnicity Indian
- •2\.Overweight/Obese adult male and female subjects in the age range 30\-65 years, body mass index (BMI) 23\-35 kg/m2
- •3\.Waist circumference: men 90 cm, women 80 cm
- •4\.Glycosylated haemoglobin (HbA1C) 5\.7% to 6\.4% and Fasting blood sugar (FBS) greater than 100 mg/dl OR diagnosed case of diabetes on anti\-diabetic medication or undiagnosed with HbA1C greater than 6\.4%
- •5\.Systolic Blood Pressure greater than 130 mmHg and Diastolic Blood Pressure greater than 85 mmHg Or Subjects on Anti\-hypertensive medication.
- •6\.Serum Triglycerides greater than 150 mg/dl
- •7\.Willingness to give written informed consent (prior to any study related procedures being performed) and ability to adhere to the study restrictions and assessments schedule.
- •For Healthy volunteers:
- •1\.Ethnicity Indian
Exclusion Criteria
- •Glycosylated haemoglobin (HbA1C) 5\.7% to 6\.4% and fasting blood sugar (FBS) more than 100 mg/dl OR diagnosed case of diabetes on anti\-diabetic medication or undiagnosed with HbA1C greater than 6\.4%
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
A study investigating the effectiveness, safety and quality of life in participants with age related visual impairment (macular degeneration) who have switched to faricimab, under real world conditions in Germanyeovascular age related macular degeneration (nAMD)Eye DiseasesISRCTN27514808Roche Pharma (Roche Germany)620
Completed
Not Applicable
Study to determine the local prevalence in Indian patients in Prostate cancerCTRI/2021/12/038578AstraZeneca Pharma India Ltd211
Completed
Not Applicable
A Non-interventional, multicentre study to see prevalence of BRCA1 and BRCA2 mutation among ovarian, primary peritoneal and fallopian tube cancer patients in IndiaCTRI/2018/08/015338AstraZeneca Pharma India Ltd
Unknown
Not Applicable
on-drug study to assess the suitability of assessment scales in Japanese individuals with Down syndrome aged 6-30Down SyndromeJPRN-jRCT1080222828Chugai Pharmaceutical Co., Ltd.40
Completed
Not Applicable
A non-interventional, cross-sectional study to investigate the burden of disease in patients with uncontrolled severe asthma in Japan by internet surveyBronchial asthmaJPRN-UMIN000028081AstraZeneca K.K.4,000